Tilray Stock: Stay on the Sidelines Until Regulatory Clarity, Says Analyst
It’s safe to say Tilray’s (NASDAQ:TLRY) fiscal third quarter earnings did not chime well with investors who sent the Canadian cannabis producer’s shares down by 20% in the subsequent session. Specifically, revenue climbed by 29.3% […]